We at Kainomyx are committed to aiding in the eradication of malaria worldwide. Unlike conventional approaches for developing treatments for humans infected by parasites, our strategy aims to identify therapeutics for malaria and other parasitic diseases by beginning with precise molecular information about how a drug will hinder a parasite. We seek equity in global health by mitigating crises that have long ravaged non-western nations and that now threaten the globe due to transnational travel and alterations in climate.

Company Information

April 20, 2022